Julie Harrison, ASQ, CQA, brings over 20 years of regulated industry experience to her role as AVEO’s Vice President, GXP Quality Assurance, including pharmaceuticals and medical device operations, project management, quality systems, validation, and drug product commercialization. Prior to joining AVEO, Ms. Harrison served as Director, Quality Assurance at Stealth Biotherapeutics managing the QA responsibilities for commercialization of both US- and EU-based drug products.
Julie has also been responsible for QA-related commercialization activities with previous companies including Acambis, supporting the licensure of ACAM2000™. In addition to these positions within operating companies, Julie has also served as a lead consultant to various pharmaceutical and medical device companies including Pfizer, Getinge and Genzyme. Julie holds a B.S. in Health Sciences from Quinnipiac University, and an A.A. in Biotechnology from North Shore Community College.